Back
NATIONAL COMPANY LAW TRIBUNAL
K. Biswal, Manoj Kumar Dubey, JJ
M/s. Biofusion Therapeutics Ltd. – Appellant
Versus
M/s. Biocon Pharma Ltd. – Respondent
| Table of Content |
|---|
| 1. details on the petition and scheme of amalgamation (Para 1 , 2 , 5 , 6 , 7 , 9 , 10 , 11) |
| 2. responses to regulatory and official liquidator observations (Para 3 , 4 , 8 , 13 , 15 , 17) |
| 3. observations by regulatory authorities and compliance (Para 12 , 14 , 16 , 18 , 19) |
| 4. court's summary of objection responses (Para 20 , 21) |
| 5. approval of the amalgamation scheme and conditions (Para 22 , 23 , 24) |
ORDER
Per: Manoj Kumar Dubey, Member (Technical)
1. This is a second motion Petition filed on 13.09.2023 by M/s. Biocon Therapeutics Limited (for brevity, the “Petitioner Company No.1/ Transferor Company”) and M/s. Biocon Pharma Limited (for brevity, the “Petitioner Company No.2/ Transferee Company”)under Section 230 to 232 and other relevant provisions of the Companies Act, 2013 , seeking for the sanction of Scheme of Amalgamation between the Transferee Company and Transferor Company w.e.f. the Appointed Date or such other date as determined in terms of the Scheme, so as to be binding on all the Shareholders and Creditors of the Transferor and Transferee Companies and that the Transferor Company/ Petitioner Company No.1 namely Biofusion Therapeutics Limited be dissolved wi
An indispensable Tool for Legal Professionals, Endorsed by Various High Court and Judicial Officers
Please visit our Training & Support
Center or Contact Us for assistance
Scan Me!
India’s Legal research and Law Firm App, Download now!
For Daily Legal Updates, Join us on :
Back to top
